These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28379790)

  • 1. An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials.
    Faris O; Shuren J
    N Engl J Med; 2017 Apr; 376(14):1350-1357. PubMed ID: 28379790
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 3. The new FDA reality.
    Waksman R
    Cardiovasc Revasc Med; 2014 Jan; 15(1):1-2. PubMed ID: 24444470
    [No Abstract]   [Full Text] [Related]  

  • 4. Let the spin begin. Greater transparency urged for device trials.
    Becker C
    Mod Healthc; 2005 Mar; 35(11):33. PubMed ID: 15794228
    [No Abstract]   [Full Text] [Related]  

  • 5. The Central and Unacknowledged Role of the US Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials.
    Kaplan AV; Stern AD
    JAMA Cardiol; 2018 Jan; 3(1):5-6. PubMed ID: 29094158
    [No Abstract]   [Full Text] [Related]  

  • 6. Relocating abroad. FDA sends staff overseas to help monitor imports.
    Lee J
    Mod Healthc; 2011 Oct; 41(43):32. PubMed ID: 22111150
    [No Abstract]   [Full Text] [Related]  

  • 7. An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs.
    Leighton JK; Saber H; Reaman G; Pazdur R
    Regul Toxicol Pharmacol; 2016 Aug; 79():142-143. PubMed ID: 26952647
    [No Abstract]   [Full Text] [Related]  

  • 8. What is involved in a regulatory trial investigating a new medical device?
    McKay PJ; Resendes S; Schemitsch E; Bhandari M
    J Long Term Eff Med Implants; 2007; 17(2):165-71. PubMed ID: 18540859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective.
    Sapirstein W
    Am Heart J; 2001 May; 141(5):861-3. PubMed ID: 11320379
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Food and Drug Administration and the regulation of clinical trials for endosseous implants.
    Scott PD; Runner S
    Ann Periodontol; 1997 Mar; 2(1):284-90. PubMed ID: 9151561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FDA's role in medical device clinical studies of human subjects.
    Saviola J
    J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; humanitarian use of devices--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Jul; 63(147):40825. PubMed ID: 10181716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical device development: from prototype to regulatory approval.
    Kaplan AV; Baim DS; Smith JJ; Feigal DA; Simons M; Jefferys D; Fogarty TJ; Kuntz RE; Leon MB
    Circulation; 2004 Jun; 109(25):3068-72. PubMed ID: 15226221
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of the noninferiority analysis in clinical studies.
    Bermingham EC; del Castillo JR; Radecki SV
    Equine Vet J; 2014 Jul; 46(4):399-401. PubMed ID: 24909652
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives on the U.S. FDA Bioresearch Monitoring Program.
    Gamet JE
    Qual Assur; 1995 Mar; 4(1):12-9. PubMed ID: 8520859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical devices; investigational device exemptions--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(135):38131-8. PubMed ID: 10181246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices; humanitarian use of devices--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.